252 related articles for article (PubMed ID: 8405713)
1. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM.
Fanelli CG; Epifano L; Rambotti AM; Pampanelli S; Di Vincenzo A; Modarelli F; Lepore M; Annibale B; Ciofetta M; Bottini P
Diabetes; 1993 Nov; 42(11):1683-9. PubMed ID: 8405713
[TBL] [Abstract][Full Text] [Related]
2. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.
Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Di Vincenzo A; Modarelli F; Ciofetta M; Lepore M; Annibale B; Torlone E
Diabetologia; 1994 Dec; 37(12):1265-76. PubMed ID: 7895957
[TBL] [Abstract][Full Text] [Related]
3. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
Dagogo-Jack S; Rattarasarn C; Cryer PE
Diabetes; 1994 Dec; 43(12):1426-34. PubMed ID: 7958494
[TBL] [Abstract][Full Text] [Related]
4. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
Fanelli C; Pampanelli S; Lalli C; Del Sindaco P; Ciofetta M; Lepore M; Porcellati F; Bottini P; Di Vincenzo A; Brunetti P; Bolli GB
Diabetes; 1997 Jul; 46(7):1172-81. PubMed ID: 9200653
[TBL] [Abstract][Full Text] [Related]
5. Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia.
Pampanelli S; Fanelli C; Lalli C; Ciofetta M; Sindaco PD; Lepore M; Modarelli F; Rambotti AM; Epifano L; Di Vincenzo A; Bartocci L; Annibale B; Brunetti P; Bolli GB
Diabetologia; 1996 Jun; 39(6):677-86. PubMed ID: 8781763
[TBL] [Abstract][Full Text] [Related]
6. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM.
Levy CJ; Kinsley BT; Bajaj M; Simonson DC
Diabetes Care; 1998 Aug; 21(8):1330-8. PubMed ID: 9702443
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.
Dagogo-Jack SE; Craft S; Cryer PE
J Clin Invest; 1993 Mar; 91(3):819-28. PubMed ID: 8450063
[TBL] [Abstract][Full Text] [Related]
8. Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM.
Hoffman RP; Singer-Granick C; Drash AL; Becker DJ
Diabetes Care; 1991 Feb; 14(2):81-8. PubMed ID: 2060427
[TBL] [Abstract][Full Text] [Related]
9. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
Kinsley BT; Weinger K; Bajaj M; Levy CJ; Simonson DC; Quigley M; Cox DJ; Jacobson AM
Diabetes Care; 1999 Jul; 22(7):1022-8. PubMed ID: 10388961
[TBL] [Abstract][Full Text] [Related]
10. Improved counter-regulatory hormonal and symptomatic responses to hypoglycemia in patients with insulin-dependent diabetes mellitus after 3 months of less strict glycemic control.
Liu D; McManus RM; Ryan EA
Clin Invest Med; 1996 Apr; 19(2):71-82. PubMed ID: 8697673
[TBL] [Abstract][Full Text] [Related]
11. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes.
Fanelli CG; Paramore DS; Hershey T; Terkamp C; Ovalle F; Craft S; Cryer PE
Diabetes; 1998 Dec; 47(12):1920-7. PubMed ID: 9836525
[TBL] [Abstract][Full Text] [Related]
12. Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans.
Davis MR; Shamoon H
Metabolism; 1992 Feb; 41(2):216-23. PubMed ID: 1736045
[TBL] [Abstract][Full Text] [Related]
13. Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM.
Hirsch IB; Boyle PJ; Craft S; Cryer PE
Diabetes; 1991 Sep; 40(9):1177-86. PubMed ID: 1657673
[TBL] [Abstract][Full Text] [Related]
14. Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes.
Davis M; Mellman M; Friedman S; Chang CJ; Shamoon H
Am J Med; 1994 Dec; 97(6):535-42. PubMed ID: 7985713
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Segel SA; Paramore DS; Cryer PE
Diabetes; 2002 Mar; 51(3):724-33. PubMed ID: 11872673
[TBL] [Abstract][Full Text] [Related]
16. Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children.
Amiel SA; Simonson DC; Sherwin RS; Lauritano AA; Tamborlane WV
J Pediatr; 1987 Jun; 110(6):832-7. PubMed ID: 3585599
[TBL] [Abstract][Full Text] [Related]
17. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.
Amiel SA; Sherwin RS; Simonson DC; Tamborlane WV
Diabetes; 1988 Jul; 37(7):901-7. PubMed ID: 3290007
[TBL] [Abstract][Full Text] [Related]
18. Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control.
Clarke WL; Gonder-Frederick LA; Richards FE; Cryer PE
Diabetes; 1991 Jun; 40(6):680-5. PubMed ID: 2040384
[TBL] [Abstract][Full Text] [Related]
19. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.
Davis MR; Mellman M; Shamoon H
Diabetes; 1992 Oct; 41(10):1335-40. PubMed ID: 1397708
[TBL] [Abstract][Full Text] [Related]
20. Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus.
Ovalle F; Fanelli CG; Paramore DS; Hershey T; Craft S; Cryer PE
Diabetes; 1998 Sep; 47(9):1472-9. PubMed ID: 9726237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
